Previous close | 297.00 |
Open | 303.01 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1000 |
Day's range | 297.35 - 303.73 |
52-week range | 215.96 - 335.83 |
Volume | |
Avg. volume | 1,110,587 |
Market cap | 79.74B |
Beta (5Y monthly) | 1.67 |
PE ratio (TTM) | 15.88 |
EPS (TTM) | 18.98 |
Earnings date | 26 Apr 2024 |
Forward dividend & yield | 2.64 (0.89%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | 338.75 |
NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA & BOSTON, April 19, 2024--Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research studies published today in the Journal of the American Medical Association (JAMA).
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Key Insights HCA Healthcare to hold its Annual General Meeting on 25th of April Total pay for CEO Sam Hazen includes...